Clinical characteristics of patients with difficult-to-treat ulcerative colitis: a nested case-control study using a Japanese claims database
The proportion of D2T UC patients among UC patients starting advanced therapy was 16.7%. The factor most associated with D2T UC was the need for a corticosteroid dose ≥ 30 mg/day during the 6 months before initiation of advanced therapy.
Authors
- Ayako Shoji (ORCID: https://orcid.org/0000-0002-1077-6393)
- Katsuyoshi Matsuoka (ORCID: https://orcid.org/0000-0002-2950-7660)
- Ataru Igarashi (ORCID: https://orcid.org/0000-0001-6307-6916)
- Naomi Mizuno (ORCID: https://orcid.org/0000-0002-1326-9792)
- Manabu Ishii (ORCID: https://orcid.org/0009-0008-3406-2150)
- Noriko Sato (ORCID: https://orcid.org/0000-0003-2660-0808)
- Masato Iizuka
- Tadakazu Hisamatsu
- Katsuhiko Iwasaki
Institutions
- Toho University (JP)
- Kyorin University (JP)
- Tokyo Health Care University (JP)
- Asahi Kasei (Japan) (JP)
- Toho University Medical Center Sakura Hospital (JP)
- The University of Tokyo (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Intestinal Research
- Published
- 2025-04-25
- DOI
- https://doi.org/10.5217/ir.2024.00119
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 1.82
Funders
- Mitsubishi Tanabe Pharma Corporation